Mostrando 2 resultados de: 2
Subtipo de publicación
Article(2)
Objetivos de Desarrollo Sostenible
ODS 10: Reducción de las desigualdades(2)
ODS 3: Salud y bienestar(2)
Origen
scopus(2)
Medical conditions in patients with pancreatic and biliary diseases: Validity and agreement between data from questionnaires and medical records
ArticleAbstract: The aims of the study were to assess the agreement between data from personal interviews and medicalPalabras claves:agreement, Interview data, Medical history, Pancreatobiliary diseases, PREVALENCE, validityAutores:Alvarez A., Andreu M., Barberà V., Barón J.M., Bellmunt J., Calafell J., Carrato A., Carrillo E., Coll S., Conangla M., Corominas J.M., Cortes I., Cosafreda S., Cugat E., De Diego M., De Miguel P., De Torre I., Espinós J.C., Fernandez E., Forteza J., Garcia De Herreros A., García-Olivares E., Gavaldà , Gómez E., Gómez J., Guaraz R., Guarner L., Gubern J.M., Lacueva F.J., Maguire A., Malats N., Maristany T., Marrugat M., Maruenda J.A., Murio E., Nadal A., Obrador N.M.A., Ojeda J.A., Orduña A., Panadès A., Pinõl J.L., Pons O., Porta M., PuigDiví V., Real F.X., Rifà J., Ruiz J., Salas A., Saus C., Serrat A., Sillero C., Solà R., Soler M., Tallada N., Terrasa T., Teruel A., Torà M., Tous F., Washington Stalin García CuentaFuentes:scopusPharmacodynamic trial of nimotuzumab in unresectable squamous cell carcinoma of the head and neck: A SENDO Foundation study
ArticleAbstract: Purpose: To assess the pharmacodynamic effects of nimotuzumab, an anti-epidermal growth factor recepPalabras claves:Autores:Albanell J., Bellosillo B., Campas C., Cedeño M., Corominas J.M., Corradino I., Cruz T., Gascon P., Gracias E., Iznaga N., Marsoni S., Osorio M., Rojo F., Rovira A., Serrano S., Sessa C., Tania Crombet, Villena N.Fuentes:scopus